Correction: Ifn-γ stimulates autophagy-mediated clearance of burkholderia cenocepacia in human cystic fibrosis macrophages(PLoS ONE (2014) 9:5 (e96681) DOI: 10.1371/journal.pone.0096681);IFN-γ stimulates autophagy-mediated clearance of Burkholderia cenocepacia in human cystic fibrosis macrophages

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Assani, Kaivon ^a   Tazi, Mia F ^b   Amer, Amal O ^b   Kopp, Benjamin T ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PROTEIN P62; AZITHROMYCIN; IFNG PROTEIN, HUMAN; INTERLEUKIN 1BETA;

ADULT; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BACTERIAL CLEARANCE; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA INFECTION; CELL ACTIVATION; CELL MIGRATION; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; LYSOSOME; MACROPHAGE; MALE; MONOCYTE; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; ADOLESCENT; CHEMISTRY; CHILD; CONFOCAL MICROSCOPY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PHAGOSOME; YOUNG ADULT;

ADOLESCENT; ADULT; AUTOPHAGY; AZITHROMYCIN; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA INFECTIONS; CHILD; CYSTIC FIBROSIS; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; LYSOSOMES; MACROPHAGES; MALE; MICROSCOPY, CONFOCAL; MONOCYTES; PHAGOSOMES; YOUNG ADULT;

EID: 84900457679     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0213092     Document Type: Erratum

References (67)

1. Grasemann H, Ratjen F (2013) Early lung disease in cystic fibrosis. Lancet Respir Med 1: 148-157.
2. Kreda SM, Davis CW, Rose MC (2012) CFTR, mucins, and mucus obstruction in cystic fibrosis. Cold Spring Harb Perspect Med 2: a009589.
3. Govan JR, Brown PH, Maddison J, Doherty CJ, Nelson JW, et al. (1993) Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342: 15-19. (Pubitemid 23183915)
4. Sun L, Jiang RZ, Steinbach S, Holmes A, Campanelli C, et al. (1995) The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med 1: 661-666.
5. Walsh NM, Casano AA, Manangan LP, Sinkowitz-Cochran RL, Jarvis WR (2002) Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis. J Pediatr 141: 512-517. (Pubitemid 35193316)
6. Drevinek P, Mahenthiralingam E (2010) Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infect 16: 821-830.
7. Jones AM, Dodd ME, Govan JR, Barcus V, Doherty CJ, et al. (2004) Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax 59: 948-951. (Pubitemid 39490778)
8. Isles A, Maclusky I, Corey M, Gold R, Prober C, et al. (1984) Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 104: 206-210. (Pubitemid 14188925)
9. Alexander BD, Petzold EW, Reller LB, Palmer SM, Davis RD, et al. (2008) Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant 8: 1025-1030. (Pubitemid 351537763)
10. De Soyza A, Meachery G, Hester KL, Nicholson A, Parry G, et al. (2010) Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience. J Heart Lung Transplant 29: 1395-1404.
11. Egan TM, Detterbeck FC, Mill MR, Bleiweis MS, Aris R, et al. (2002) Long term results of lung transplantation for cystic fibrosis. Eur J Cardiothorac Surg 22: 602-609. (Pubitemid 35286946)
12. Murray S, Charbeneau J, Marshall BC, LiPuma JJ (2008) Impact of burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med 178: 363-371.
13. Olland A, Falcoz PE, Kessler R, Massard G (2011) Should cystic fibrosis patients infected with Burkholderia cepacia complex be listed for lung transplantation? Interact Cardiovasc Thorac Surg 13: 631-634.
14. Brennan S, Sly PD, Gangell CL, Sturges N, Winfield K, et al. (2009) Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis. Eur Respir J 34: 655-661.
15. Bruscia EM, Zhang PX, Ferreira E, Caputo C, Emerson JW, et al. (2009) Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-/- mice. Am J Respir Cell Mol Biol 40: 295-304.
16. Bruscia EM, Zhang PX, Satoh A, Caputo C, Medzhitov R, et al. (2011) Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis. J Immunol 186: 6990-6998.
17. Del Porto P, Cifani N, Guarnieri S, Di Domenico EG, Mariggio MA, et al. (2011) Dysfunctional CFTR alters the bactericidal activity of human macrophages against Pseudomonas aeruginosa. PLoS One 6: e19970.
18. Hartl D, Gaggar A, Bruscia E, Hector A, Marcos V, et al. (2012) Innate immunity in cystic fibrosis lung disease. J Cyst Fibros 11: 363-382.
19. Kopp BT, Abdulrahman BA, Khweek AA, Kumar SB, Akhter A, et al. (2012) Exaggerated inflammatory responses mediated by Burkholderia cenocepacia in human macrophages derived from Cystic fibrosis patients. Biochem Biophys Res Commun 424: 221-227.
20. Vandivier RW, Richens TR, Horstmann SA, deCathelineau AM, Ghosh M, et al. (2009) Dysfunctional cystic fibrosis transmembrane conductance regulator inhibits phagocytosis of apoptotic cells with proinflammatory consequences. Am J Physiol Lung Cell Mol Physiol 297: L677-686.
21. Di A, Brown ME, Deriy LV, Li C, Szeto FL, et al. (2006) CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol 8: 933-944. (Pubitemid 44314724)
22. Abdulrahman BA, Khweek AA, Akhter A, Caution K, Kotrange S, et al. (2011) Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis. Autophagy 7: 1359-1370.
23. Kotrange S, Kopp B, Akhter A, Abdelaziz D, Abu Khweek A, et al. (2011) Burkholderia cenocepacia O polysaccharide chain contributes to caspase-1-dependent IL-1beta production in macrophages. J Leukoc Biol 89: 481-488.
24. Vergunst AC, Meijer AH, Renshaw SA, O'Callaghan D (2010) Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection. Infect Immun 78: 1495-1508.
25. Luciani A, Villella VR, Esposito S, Brunetti-Pierri N, Medina D, et al. (2010) Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat Cell Biol 12: 863-875.
26. Abdulrahman BA, Khweek AA, Akhter A, Caution K, Tazi M, et al. (2013) Depletion of the ubiquitin-binding adaptor molecule SQSTM1/p62 from macrophages harboring cftr DeltaF508 mutation improves the delivery of Burkholderia cenocepacia to the autophagic machinery. J Biol Chem 288: 2049-2058.
27. Yuan K, Huang C, Fox J, Laturnus D, Carlson E, et al. (2012) Autophagy plays an essential role in the clearance of Pseudomonas aeruginosa by alveolar macrophages. J Cell Sci 125: 507-515.
28. Schnaith A, Kashkar H, Leggio SA, Addicks K, Kronke M, et al. (2007) Staphylococcus aureus subvert autophagy for induction of caspase-independent host cell death. J Biol Chem 282: 2695-2706. (Pubitemid 47076780)
29. Mayer ML, Blohmke CJ, Falsafi R, Fjell CD, Madera L, et al. (2013) Rescue of Dysfunctional Autophagy Attenuates Hyperinflammatory Responses from Cystic Fibrosis Cells. J Immunol 190: 1227-1238.
30. Luciani A, Villella VR, Esposito S, Gavina M, Russo I, et al. (2012) Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on DeltaF508 cystic fibrosis transmembrane conductance regulator. Autophagy 8: 1657-1672.
31. Hardinger KL, Cornelius LA, Trulock EP, 3rd, Brennan DC (2002) Sirolimus-induced leukocytoclastic vasculitis. Transplantation 74: 739-743.
32. Chhajed PN, Dickenmann M, Bubendorf L, Mayr M, Steiger J, et al. (2006) Patterns of pulmonary complications associated with sirolimus. Respiration 73: 367-374. (Pubitemid 43725797)
33. Fernandez-Boyanapalli R, McPhillips KA, Frasch SC, Janssen WJ, Dinauer MC, et al. (2010) Impaired phagocytosis of apoptotic cells by macrophages in chronic granulomatous disease is reversed by IFN-gamma in a nitric oxide-dependent manner. J Immunol 185: 4030-4041.
34. (1991) A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med 324: 509-516.
35. Errante PR, Frazao JB, Condino-Neto A (2008) The use of interferon-gamma therapy in chronic granulomatous disease. Recent Pat Antiinfect Drug Discov 3: 225-230.
36. McPhail LC, DeChatelet LR, Shirley PS, Wilfert C, Johnston RB Jr, et al. (1977) Deficiency of NADPH oxidase activity in chronic granulomatous disease. J Pediatr 90: 213-217. (Pubitemid 8033509)
37. Sanmun D, Witasp E, Jitkaew S, Tyurina YY, Kagan VE, et al. (2009) Involvement of a functional NADPH oxidase in neutrophils and macrophages during programmed cell clearance: implications for chronic granulomatous disease. Am J Physiol Cell Physiol 297: C621-631.
38. Al-Khodor S, Marshall-Batty K, Nair V, Ding L, Greenberg DE, et al. (2014) Burkholderia cenocepacia J2315 escapes to the cytosol and actively subverts autophagy in human macrophages. Cell Microbiol 16: 378-395.
39. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, et al. (2004) Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119: 753-766. (Pubitemid 40017683)
40. Holland SM (2010) Chronic granulomatous disease. Clin Rev Allergy Immunol 38: 3-10.
41. Moss RB, Mayer-Hamblett N, Wagener J, Daines C, Hale K, et al. (2005) Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease. Pediatr Pulmonol 39: 209-218. (Pubitemid 40460688)
42. Hamad MA, Skeldon AM, Valvano MA (2010) Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay. Appl Environ Microbiol 76: 3170-3176.
43. Akhter A, Gavrilin MA, Frantz L, Washington S, Ditty C, et al. (2009) Caspase-7 activation by the Nlrc4/Ipaf inflammasome restricts Legionella pneumophila infection. PLoS Pathog 5: e1000361.
44. Renna M, Schaffner C, Brown K, Shang S, Tamayo MH, et al. (2011) Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest 121: 3554-3563.
45. Binder AM, Adjemian J, Olivier KN, Prevots DR (2013) Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. Am J Respir Crit Care Med 188: 807-812.
46. Al-Zeer MA, Al-Younes HM, Lauster D, Abu Lubad M, Meyer TF (2013) Autophagy restricts Chlamydia trachomatis growth in human macrophages via IFNG-inducible guanylate binding proteins. Autophagy 9: 50-62.
47. Matsuzawa T, Kim BH, Shenoy AR, Kamitani S, Miyake M, et al. (2012) IFN-gamma elicits macrophage autophagy via the p38 MAPK signaling pathway. J Immunol 189: 813-818.
48. Moser C, Kjaergaard S, Pressler T, Kharazmi A, Koch C, et al. (2000) The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS 108: 329-335. (Pubitemid 30456361)
49. Komatsu M, Kageyama S, Ichimura Y (2012) p62/SQSTM1/A170: physiology and pathology. Pharmacol Res 66: 457-462.
50. McKeon S, McClean S, Callaghan M (2010) Macrophage responses to CF pathogens: JNK MAP kinase signaling by Burkholderia cepacia complex lipopolysaccharide. FEMS Immunol Med Microbiol 60: 36-43.
51. Gillette DD, Shah PA, Cremer T, Gavrilin MA, Besecker BY, et al. (2013) Analysis of human bronchial epithelial cell proinflammatory response to Burkholderia cenocepacia infection: inability to secrete il-1beta. J Biol Chem 288: 3691-3695.
52. Gavrilin MA, Abdelaziz DH, Mostafa M, Abdulrahman BA, Grandhi J, et al. (2012) Activation of the Pyrin Inflammasome by Intracellular Burkholderia cenocepacia. J Immunol 188: 3469-3477.
53. Jain MV, Paczulla AM, Klonisch T, Dimgba FN, Rao SB, et al. (2013) Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development. J Cell Mol Med 17: 12-29.
54. Van de Weert-van Leeuwen PB, Van Meegen MA, Speirs JJ, Pals DJ, Rooijakkers SH, et al. (2013) Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator-dependent. Am J Respir Cell Mol Biol 49: 463-470.
55. Sajjan SU, Carmody LA, Gonzalez CF, LiPuma JJ (2008) A type IV secretion system contributes to intracellular survival and replication of Burkholderia cenocepacia. Infect Immun 76: 5447-5455.
56. Junkins RD, Shen A, Rosen K, McCormick C, Lin TJ (2013) Autophagy enhances bacterial clearance during P. aeruginosa lung infection. PLoS One 8: e72263.
57. Farrar MA, Schreiber RD (1993) The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 11: 571-611. (Pubitemid 23115018)
58. Condos R, Hull FP, Schluger NW, Rom WN, Smaldone GC (2004) Regional deposition of aerosolized interferon-gamma in pulmonary tuberculosis. Chest 125: 2146-2155. (Pubitemid 38788183)
59. Diaz KT, Skaria S, Harris K, Solomita M, Lau S, et al. (2012) Delivery and safety of inhaled interferon-gamma in idiopathic pulmonary fibrosis. J Aerosol Med Pulm Drug Deliv 25: 79-87.
60. Johansen HK, Hougen HP, Rygaard J, Hoiby N (1996) Interferon-gamma (IFN-gamma) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats. Clin Exp Immunol 103: 212-218. (Pubitemid 26045361)
61. Marciano BE, Wesley R, De Carlo ES, Anderson VL, Barnhart LA, et al. (2004) Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 39: 692-699. (Pubitemid 39180442)
62. Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, et al. (2012) Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 13: 255-263.
63. Mitchell AJ, Yau B, McQuillan JA, Ball HJ, Too LK, et al. (2012) Inflammasome-dependent IFN-gamma drives pathogenesis in Streptococcus pneumoniae meningitis. J Immunol 189: 4970-4980.
64. Lamothe J, Valvano MA (2008) Burkholderia cenocepacia-induced delay of acidification and phagolysosomal fusion in cystic fibrosis transmembrane conductance regulator (CFTR)-defective macrophages. Microbiology 154: 3825-3834.
65. Subramoni S, Sokol PA (2012) Quorum sensing systems influence Burkholderia cenocepacia virulence. Future Microbiol 7: 1373-1387.
66. Aubert DF, O'Grady EP, Hamad MA, Sokol PA, Valvano MA (2013) The Burkholderia cenocepacia sensor kinase hybrid AtsR is a global regulator modulating quorum-sensing signalling. Environ Microbiol 15: 372-385.
67. O'Grady EP, Viteri DF, Sokol PA (2012) A unique regulator contributes to quorum sensing and virulence in Burkholderia cenocepacia. PLoS One 7: e37611.